| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-27 | FY 2024
FILED 2024-09-28 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $3.20B | $2.19B | $2.27B |
| YoY Revenue Growth % | +46.5% | -3.9% | — |
| Gross Profit | $337.0M | $237.0M | — |
| Gross Margin % | 10.5% | 10.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.0M | -$141.0M | $2.7M |
| Operating Margin % | 0.2% | -6.4% | 0.1% |
| Net Income (GAAP) | -$159.0M | -$154.0M | -$79.1M |
| EBITDA (Normalized) | $58.6M | -$83.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $103.0M | $192.0M | $257.0M |
| Capital Expenditures (CapEx) | $67.0M | $72.0M | — |
| Free Cash Flow (FCF) | $36.0M | $120.0M | $257.0M |
| FCF Margin % | 1.1% | 5.5% | 11.3% |
| Return on Invested Capital (ROIC %) | 0.1% | -3.9% | — |
| Cash & Short-Term Equivalents | $264.0M | $215.0M | — |
| Total Debt (Short + Long Term) | $1.93B | $1.99B | — |
| Total Stockholders' Equity | $1.04B | $1.11B | — |